Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 10 2021
Historique:
received: 20 12 2020
accepted: 16 09 2021
entrez: 8 10 2021
pubmed: 9 10 2021
medline: 17 7 2022
Statut: epublish

Résumé

Particulate respirators such as N95s are an essential component of personal protective equipment (PPE) for front-line workers. This study describes a rapid and effective UVC irradiation system that would facilitate the safe re-use of N95 respirators and provides supporting information for deploying UVC for decontamination of SARS-CoV-2 during the COVID-19 pandemic. To assess the inactivation potential of the proposed UVC germicidal device as a function of time by using 3 M 8211-N95 particulate respirators inoculated with SARS-CoV-2. A germicidal UVC device to deliver tailored UVC dose was developed and test coupons (2.5 cm

Identifiants

pubmed: 34620951
doi: 10.1038/s41598-021-99431-5
pii: 10.1038/s41598-021-99431-5
pmc: PMC8497543
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19970

Subventions

Organisme : NIH CTSA
ID : 5UL1TR001433
Organisme : Open Philanthropy Project
ID : 2020-215611 (5384)
Organisme : NIH HHS
ID : 5UL1 TR001433
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001433
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93019C00028
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI097092
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2021. The Author(s).

Références

Public Health Rep. 2010 Jan-Feb;125(1):15-27
pubmed: 20402193
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
J Occup Environ Hyg. 2015;12(8):509-17
pubmed: 25806411
Saf Sci. 2020 Sep;129:104830
pubmed: 32406406
Lancet Microbe. 2020 Aug;1(4):e146
pubmed: 33521712
Med Microbiol Immunol. 2005 Jan;194(1-2):1-6
pubmed: 15118911
Am Econ Rev. ;95(2):258-62
pubmed: 29125265
Burns. 2020 Jun;46(4):842-849
pubmed: 31676249
Ann Occup Hyg. 2009 Nov;53(8):815-27
pubmed: 19805391
Ann Occup Hyg. 2012 Jan;56(1):92-101
pubmed: 21859950
Sci Rep. 2021 Jan 13;11(1):984
pubmed: 33441775
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Dermatology. 2006;212 Suppl 1:119-23
pubmed: 16490989
J Hosp Infect. 2020 Sep;106(1):163-175
pubmed: 32687870
J Ind Microbiol Biotechnol. 2017 Jun;44(6):893-909
pubmed: 28283956
JAMA. 2020 May 19;323(19):1911
pubmed: 32196543
Am J Infect Control. 2011 Feb;39(1):e1-9
pubmed: 21145624
PLoS One. 2019 Feb 21;14(2):e0212332
pubmed: 30789926
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
Virulence. 2012 Jul 1;3(4):351-67
pubmed: 22722247
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32579874
J Virol. 2005 Nov;79(22):14244-52
pubmed: 16254359
Ann Work Expo Health. 2019 Oct 11;63(8):930-936
pubmed: 31504129
Virol J. 2020 Oct 7;17(1):145
pubmed: 33028356
Am J Infect Control. 2012 May;40(4):375-80
pubmed: 21864945
Biomed Environ Sci. 2003 Sep;16(3):246-55
pubmed: 14631830
J Virol Methods. 2004 Oct;121(1):85-91
pubmed: 15350737
Exp Biol Med (Maywood). 2020 Jun;245(11):933-939
pubmed: 32397762
Clin Infect Dis. 2005 Oct 1;41(7):e67-71
pubmed: 16142653
J Biosci Bioeng. 2018 Jul;126(1):63-68
pubmed: 29490883

Auteurs

Raveen Rathnasinghe (R)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Robert F Karlicek (RF)

Smart Lighting Engineering Research Center, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.
Department of Electrical Computer and Systems Engineering, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.

Michael Schotsaert (M)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Mattheos Koffas (M)

Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.
Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.
Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.

Brigitte L Arduini (BL)

Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.

Sonia Jangra (S)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Bowen Wang (B)

Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.
Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.

Jason L Davis (JL)

Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.

Mohammed Alnaggar (M)

Department of Civil and Environmental Engineering, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.

Anthony Costa (A)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Richard Vincent (R)

Department of Medicine, Section of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Adolfo García-Sastre (A)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Deepak Vashishth (D)

Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA. vashid@rpi.edu.
Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA. vashid@rpi.edu.

Priti Balchandani (P)

BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. priti.balchandani@mssm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH